Clozapine and body mass change

Biological Psychiatry

Volumn 43, Issue 7, 1998, Pages 520-524

  Frankenburg, Frances R ^a   Zanarini, Mary C ^b   Kando, Judy ^b   Centorrino, Franca ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

Body mass; Cardiovascular risk factor; Clozapine; Weight gain

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY RISK; DEPRESSION; DRUG EFFECT; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; WEIGHT GAIN;

ADULT; ANTHROPOMETRY; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; BODY WEIGHT; CLOZAPINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; SEX CHARACTERISTICS;

EID: 0032054903     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00488-5     Document Type: Article

References (32)

1. Alexander H, Dugdale A (1992): Proper use of the waist to hip ratio. Med J Aust 157:141-142.
2. Baldessarini RJ, Frankenburg FR (1991): Clozapine. A novel antipsychotic agent. N Engl J Med 324:746-754.
3. Bjorntop P (1985): Obesity and the risk of cardiovascular disease. Ann Clin Res 17:3-9.
4. Bustillo JR, Buchanan RW, Irish D, Breier A (1996): Differential effect of clozapine on weight: A controlled study. Am J Psychiatry 153:817-819.
5. Cohen S, Chiles J, MacNaughton A (1990): Weight gain associated with clozapine. Am J Psychiatry 147:503-504.
6. Garrison RJ, Kannel WB (1993): A new approach for estimating healthy body weights. Int J Obe Relat Metab Disord 17:417-423.
7. George TP, Sernyak MJ, Ziedonis DM, Woods SW (1995): Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry 156:344-346.
8. Gerlach J, Jørgensen EO, Peacock L (1989): Long-term experience with clozapine in Denmark: Research and clinical practice. Psychopharmacology 99(suppl 1):S92-S96.
9. Grunberg NE (1991): Smoking cessation and weight gain. N Engl J Med 324:768-769.
10. Hemphill RE, Pascoe FD, Zabow T (1975): An investigation of clozapine in the treatment of acute and chronic schizophrenia and gross behavior disorders. S Afr Med J 49:2121-2125.
11. Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H, Fleischhacker W (1995): Weight gain induced by clozapine. Eur Neuropsychopharmacol 5:437-440.
12. Jalenques A, Coudert AJ (1994): Clozapine et schizophrénies résistantes. Étude prospective à long terme chez vingt patients. Encephale 20:767-775.
13. John JP, Chengappa KNR, Baker RW, Gupta B, Mortimer MT (1995): Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients. Ann Clin Psychiatry 7:119-125.
14. Juul Povlsen U, Noring U, Fog R, Gerlach J (1985): Tolerability and therapeutic effect of clozapine. Acta Psychiatr Scand 71:176-178.
15. Kane J, Honigfeld G, Singer J, Meltzer H (1988): Clozapine for treatment-resistant schizophrenia: A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796.
16. Lamberti JS, Bellnier T, Schwarzkopf SB (1992): Weight gain among schizophrenic patients treated with clozapine. Am J Psychiatry 149:689-690.
17. Leadbetter R, Shutty M, Pavalonis D, Vieweg V, Higgins P, Downs M (1992): Clozapine-induced weight gain: Prevalence and clinical relevance. Am J Psychiatry 149:68-72.
18. Lee I-M, Manson JE, Hennekens CH, Paffenbarger RS (1993): Body weight and mortality. A 27-year follow-up of middle-aged men. JAMA 270:2823-2828.
19. Leppig M, Bosch B, Naber D, Hippius H (1989): Clozapine in the treatment of 121 out-patients. Psychopharmacology 99(suppl 1):S77-S79.
20. Meltzer HY, Okayli G (1995): Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact on risk-benefit assessment. Am J Psychiatry 152:183-190.
21. Naber D, Holzbach R, Perro C, Hippius H (1992): Clinical management of clozapine patients in relation to efficacy and side-effects. Br J Psychiatry 160(suppl 17):54-59.
22. Nair NPV, Zicherman V, Schwartz G (1977): Dopamine and schizophrenia. A reappraisal in the light of clinical studies with clozapine. Can Psychiatr Assoc J 22:285-293.
23. Norris DL, Israelstam K (1975): Clozapine (Leponex) overdosage. S Afr Med J 49:38.
24. Peacock L, Gerlach J (1994): Clozapine treatment in Denmark: Concomitant psychotropic medication and hematological monitoring in a system with liberal usage practices. J Clin Psychiatry 55:44-49.
25. Schmauss M, Wolff R, Erfuth A, Rüther E (1989): Tolerability of long term clozapine treatment. Psychopharmacology 99(suppl 1):S105-S108.
26. Silverstone T, Smith G, Goodall E (1988): Prevalence of obesity in patients receiving depot antipsychotics. Br J Psychiatry 153:214-217.
27. Stedman T, Welham J (1993): The distribution of adipose tissue in female in-patients receiving psychotropic drugs. Br J Psychiatry 162:249-250.
28. Umbricht DS, Pollack S, Kane JM (1994): Clozapine and weight gain. J Clin Psychiatry 55(suppl B):157-160.
29. U.S. Dept. of Agriculture, U.S. Dept. of Health and Human Services (1995): Nutrition and Your Health: Dietary Guidelines for Americans, 4th ed. Washington, DC: U.S. Government Printing Office.
30. Wiebe EJ (1993): Weight gain with clozapine treatment. Can J Psychiatry 38:70.
31. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, et al (1995): Weight, weight change, and coronary heart disease in women. Risk within the "normal" weight range. JAMA 273:461-465.
32. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T (1991): Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 324:739-745.